Pacer Advisors Inc. increased its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 8.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 241,210 shares of the company’s stock after buying an additional 18,618 shares during the quarter. Pacer Advisors Inc.’s holdings in Procter & Gamble were worth $41,778,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Itau Unibanco Holding S.A. bought a new position in shares of Procter & Gamble in the second quarter valued at approximately $28,000. Fairway Wealth LLC bought a new position in Procter & Gamble during the 2nd quarter valued at $29,000. POM Investment Strategies LLC purchased a new position in Procter & Gamble during the 2nd quarter worth $34,000. Quest Partners LLC bought a new stake in shares of Procter & Gamble in the 2nd quarter worth $36,000. Finally, Fairfield Financial Advisors LTD bought a new position in shares of Procter & Gamble during the second quarter valued at about $44,000. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Performance
NYSE:PG opened at $172.68 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The firm has a market cap of $406.67 billion, a price-to-earnings ratio of 29.77, a PEG ratio of 3.69 and a beta of 0.42. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $177.94. The business’s fifty day moving average is $170.00 and its 200 day moving average is $168.54.
Procter & Gamble Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.33%. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.
Insider Activity at Procter & Gamble
In related news, CEO Jon R. Moeller sold 87,979 shares of the firm’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $170.40, for a total transaction of $14,991,621.60. Following the transaction, the chief executive officer now directly owns 300,777 shares of the company’s stock, valued at approximately $51,252,400.80. This trade represents a 22.63 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Andre Schulten sold 13,041 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the sale, the chief financial officer now owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. The trade was a 25.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 160,693 shares of company stock valued at $27,311,345. Company insiders own 0.18% of the company’s stock.
Wall Street Analysts Forecast Growth
PG has been the subject of a number of recent analyst reports. StockNews.com downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. DA Davidson reiterated a “neutral” rating and set a $160.00 price target on shares of Procter & Gamble in a report on Wednesday. Piper Sandler began coverage on Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective for the company. Evercore ISI lifted their target price on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $164.00 price objective on shares of Procter & Gamble in a report on Monday, October 21st. Nine investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $177.00.
Read Our Latest Research Report on PG
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Read More
- Five stocks we like better than Procter & Gamble
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Breakout Stocks: What They Are and How to Identify Them
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- TJX Companies Stock Poised to Hit a New High This Year
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.